Trials / Terminated
TerminatedNCT01458015
Tapentadol Versus Oxycodone - a Mechanism-based Treatment Approach in Neuropathic Pain
Phase 4 Study of Tapentadol vs Oxycodone in Neuropathic Pain
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- University Hospital Schleswig-Holstein · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to elucidate whether the additional mechanism of analgesia, i.e. reuptake inhibition of norepinephrine, of tapentadol leads to a change in different pain signs and symptoms in comparison to oxycodone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tapentadol, oxycodone | tapentadol pr 100-500 mg oxycodone cr 20-120mg |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2011-10-24
- Last updated
- 2025-01-07
- Results posted
- 2024-12-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01458015. Inclusion in this directory is not an endorsement.